Keith Flaherty, M.D.


Physician Investigator (Cl)
CCR Group C Monthly, Mass General Research Institute
Professor of Medicine
Harvard Medical School
Associate Physician
Hematology-Oncology, Massachusetts General Hospital
MD Johns Hopkins University School of Medicine 1997
antineoplastic agents; benzenesulfonates; carcinoma, renal cell; melanoma; protein kinase inhibitors; proto-oncogene proteins b-raf; pyridines; skin neoplasms Dr. Flaherty's research focuses on the understanding of novel, molecularly targeted therapies in cancer. In this context he focused on the development of response and predictive biomarkers to define the mechanisms of action and resistance of novel therapies, as well as to identify the optimal target population.
Publications Clinical Profile
kflaherty@mgh.harvard.edu
6176435817

Lawrence House
10 North Grove Street
Boston, MA 02114